These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12732364)

  • 21. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
    Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
    Thibault G; Grove KL; Deschepper CF
    Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
    Behr TM; Jenner N; Béhé M; Angerstein C; Gratz S; Raue F; Becker W
    J Nucl Med; 1999 Jun; 40(6):1029-44. PubMed ID: 10452322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
    Barrett RW; Steffey ME; Wolfram CA
    Mol Pharmacol; 1989 Apr; 35(4):394-400. PubMed ID: 2539554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies.
    Perrin MH; Tan LA; Vaughan JM; Lewis KA; Donaldson CJ; Miller C; Erchegyi J; Rivier JE; Sawchenko PE
    J Pharmacol Exp Ther; 2015 May; 353(2):307-17. PubMed ID: 25736419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric chief cells possess NK1 receptors which mediate pepsinogen secretion and are regulated by agents that increase cAMP and phospholipase C.
    Kitsukawa Y; Turner RJ; Pradhan TK; Jensen RT
    Biochim Biophys Acta; 1996 Jun; 1312(2):105-16. PubMed ID: 8672532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides.
    Bläker M; Ren Y; Seshadri L; McBride EW; Beinborn M; Kopin AS
    Mol Pharmacol; 2000 Aug; 58(2):399-406. PubMed ID: 10908308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous measurement of cholecystokinin-stimulated amylase release and cholecystokinin receptor binding in rat pancreatic acini.
    Blevins GT; Doi R; Tangoku A; Chowdhury P; McKay D; Rayford PL
    J Lab Clin Med; 1992 May; 119(5):566-73. PubMed ID: 1374786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 125I-(Thr34, Nle37)- CCK31-39 a non oxidizable tracer for the characterization of CCK receptor on pancreatic acini and radio-immunoassay of C-terminal CCK peptides.
    Fourmy D; Pradayrol L; Vaysse N; Susini C; Ribet A
    J Immunoassay; 1984; 5(1-2):99-120. PubMed ID: 6201510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line.
    Gros L; Thorens B; Bataille D; Kervran A
    Endocrinology; 1993 Aug; 133(2):631-8. PubMed ID: 8102095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic cholecystokinin analogues with high selectivity for central receptors.
    Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 130-kDa membrane protein of sperm flagella is the receptor for asterosaps, sperm-activating peptides of starfish Asterias amurensis.
    Nishigaki T; Chiba K; Hoshi M
    Dev Biol; 2000 Mar; 219(1):154-62. PubMed ID: 10677262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the radioligand binding assay of cholecystokinin receptor in rat cerebral cortex].
    Xiang P; Chen M; Tan T; Shi Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun; 30(2):214-6, 221. PubMed ID: 12212064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
    Geraghty DP; Mussap CJ; Burcher E
    Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
    Fehmann HC; Habener JF
    FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.
    Perry KJ; Quiza M; Myers DE; Morfis M; Christopoulos G; Sexton PM
    Endocrinology; 1997 Aug; 138(8):3486-96. PubMed ID: 9231803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.